Sclerosing cholangitis rapidly following anti-HIV-1 seroconversion.

AUTOR(ES)

Mercey, D E

RESUMO

A 22 year old man developed sclerosing cholangitis within two months of documented HIV-1 seroconversion. Sclerosing cholangitis should be included in the differential diagnosis of causes of abdominal pain and raised alkaline phosphatase enzyme levels in HIV-1 antibody positive patients without established CDC stage IV disease.

Documentos Relacionados

• Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate
• Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents.
• Dual role of α-defensin-1 in anti–HIV-1 innate immunity
• 7,8-secolignans from Schisandra neglecta and their anti-HIV-1 activities
• Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides